ARK Investment Management - FOAMIX PHARMACEUTICALS LTD ownership

FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 66 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q4 2019. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.

Quarter-by-quarter ownership
ARK Investment Management ownership history of FOAMIX PHARMACEUTICALS LTD
ValueSharesWeighting
Q4 2019$367,000
-38.4%
110,343
-43.7%
0.01%
-30.8%
Q3 2019$596,000
+70.8%
196,160
+33.7%
0.01%
+44.4%
Q2 2019$349,000
-20.7%
146,745
+25.0%
0.01%
-30.8%
Q1 2019$440,000
+29.8%
117,367
+24.4%
0.01%
-7.1%
Q4 2018$339,000
-40.7%
94,378
-5.5%
0.01%
-17.6%
Q3 2018$572,000
+7.5%
99,901
-6.0%
0.02%
-10.5%
Q2 2018$532,000
+14.9%
106,243
+17.7%
0.02%
-17.4%
Q1 2018$463,000
+97.0%
90,263
+130.5%
0.02%
+21.1%
Q4 2017$235,00039,1600.02%
Other shareholders

There were no reported owners of FOAMIX PHARMACEUTICALS LTD in Q4 2019.

NameSharesValueWeighting ↓
View complete list of FOAMIX PHARMACEUTICALS LTD shareholders